We are live on ! Find out more
ACM

Apex Capital Management Portfolio holdings

AUM $4.54B
1-Year Est. Return 1.74%
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+1.74%
3 Year Est. Return
+80.63%
5 Year Est. Return
10 Year Est. Return
AUM
$3.75B
AUM Growth
+$436M
Cap. Flow
+$286M
Cap. Flow %
7.63%
Top 10 Hldgs %
19.71%
Holding
267
New
24
Increased
137
Reduced
57
Closed
17

Sector Composition

Rank Sector Weight
1 Industrials 22.21%
2 Consumer Discretionary 19.42%
3 Healthcare 16.62%
4 Technology 13.68%
5 Financials 4.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
151
Pfizer
PFE
$143B
$4.33M 0.12%
146,454
-506
-0.3% -$14.5K
FANG icon
152
Diamondback Energy
FANG
$55.9B
$4.29M 0.11%
71,822
+17,417
+32% +$1.11M
REGN icon
153
Regeneron Pharmaceuticals
REGN
$78.2B
$4.1M 0.11%
9,995
-118
-1% -$46.4K
PARA
154
DELISTED
Paramount Global Class B
PARA
$3.95M 0.11%
71,433
-397
-0.6% -$21.1K
KLXI
155
DELISTED
KLX Inc.
KLXI
$3.95M 0.11%
+113,654
New +$4M
ROK icon
156
Rockwell Automation
ROK
$53.5B
$3.85M 0.1%
34,592
-276
-0.8% -$30.3K
EA icon
157
Electronic Arts
EA
$53B
$3.8M 0.1%
+80,810
New +$3.33M
DHR icon
158
Danaher
DHR
$139B
$3.7M 0.1%
64,280
-613
-0.9% -$33.2K
MTDR icon
159
Matador Resources
MTDR
$6.06B
$3.51M 0.09%
173,417
+42,547
+33% +$882K
GMED icon
160
Globus Medical
GMED
$11.1B
$3.42M 0.09%
143,807
+36,847
+34% +$816K
AFSI
161
DELISTED
AmTrust Financial Services, Inc.
AFSI
$3.4M 0.09%
121,070
+28,932
+31% +$728K
HAL icon
162
Halliburton
HAL
$26.6B
$3.17M 0.08%
80,521
-1,894
-2% -$92.2K
VIAB
163
DELISTED
Viacom Inc. Class B
VIAB
$3.16M 0.08%
41,992
-596
-1% -$43.6K
GS icon
164
Goldman Sachs
GS
$303B
$3.01M 0.08%
15,550
-139
-0.9% -$26.1K
PRIM icon
165
Primoris Services
PRIM
$4.77B
$3M 0.08%
129,191
+30,664
+31% +$767K
ACAD icon
166
Acadia Pharmaceuticals
ACAD
$4.39B
$2.97M 0.08%
93,527
+22,445
+32% +$636K
TRIP icon
167
TripAdvisor
TRIP
$1.69B
$2.77M 0.07%
37,057
+1,165
+3% +$90.9K
SLCA
168
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$2.74M 0.07%
106,612
+24,794
+30% +$979K
JMEI
169
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$2.72M 0.07%
+19,956
New +$4.06M
CBI
170
DELISTED
Chicago Bridge & Iron Nv
CBI
$2.56M 0.07%
61,037
-3,797
-6% -$187K
EJ
171
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
$2.54M 0.07%
350,990
+64,367
+22% +$552K
PCYC
172
DELISTED
PHARMACYCLICS INC
PCYC
$2.48M 0.07%
20,247
-146
-0.7% -$18.7K
PNK
173
DELISTED
Pinnacle Entertainment Inc.
PNK
$2.38M 0.06%
106,869
+25,107
+31% +$584K
VC icon
174
Visteon
VC
$2.82B
$2.37M 0.06%
22,219
-554,876
-96% -$53.5M
PCP
175
DELISTED
PRECISION CASTPARTS CORP
PCP
$2.14M 0.06%
8,866
-78
-0.9% -$18K

Similar funds

Apex Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Apex Capital Management held 267 positions worth $3.75B, up 13% from $3.32B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Apex Capital Management deployed $286M of net new capital in Q4 2014, opening 24 new positions and adding to 137 existing holdings. Its largest new stake was Universal Health Services: 662,924 shares worth $73.8M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Visteon, an estimated $53.5M trimmed.

  • Apex Capital Management's largest Q4 2014 buy was Universal Health Services: 662,924 shares worth $73.8M.
  • Apex Capital Management added most to Verint Systems in Q4 2014, an estimated $31.2M increase.
  • Apex Capital Management's biggest Q4 2014 reduction was Visteon, cutting an estimated $53.5M.
  • Apex Capital Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q4 2014, selling an estimated $59.3M.
  • Apex Capital Management's ten largest holdings make up 20% of its $3.75B portfolio in Q4 2014.
  • Apex Capital Management opened 24 new positions and closed 17 in Q4 2014.
  • Apex Capital Management's portfolio value rose 13% quarter-over-quarter to $3.75B.

Based on Apex Capital Management's 13F filing for Q4 2014, filed 20 Jan 2015.